Please login to the form below

Not currently logged in
Email:
Password:

Elisia Canna to lead expansion of GCI Health’s Well Living

She assumes executive VP role at healthcare PR firm
GCI_Elisia-Canna

GCI Health has appointed Elisia Canna to lead the healthcare PR firm's expanding consumer wellness offering Well Living.

Formerly director, consumer health, Canna is now executive VP, health and wellness. She will continue to report to GCI Health's CEO, Wendy Lund. The promotion takes effect immediately, a GCI Health representative told PMLiVE

“The new effort Elisia will be leading focuses on industry trends and the fact that so many companies and brands are delving into the wellness space and how best to communicate the most appropriate wellness paths and solutions to enhance consumers' lives,” said Lund.

“Elisia's experience in consumer health and her attention to insights that activate consumers and embrace client brands will be invaluable to our work going forward.”

Canna joined GCI Health in January 2011. She was an executive VP at Porter Novelli from 2006 to 2010. Before that she was with Ogilvy Public Relations Worldwide, as a senior vice president.

The rapidly expanding GCI Health has hired 35 new staff over the past six months, 11 of them joining the London office, including director Hannah Morris.

27th August 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...
PANDAS/PANS Awareness: A parent’s story
To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
Iskra Reic
Leading AstraZeneca’s return to growth in Europe
PME talks to Iskra Reic, the company’s head of Europe and Canada...

Infographics